The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 04, 2025
Filed:
Feb. 14, 2024
Applicant:
Guardant Health, Inc., Palo Alto, CA (US);
Inventors:
Stefanie Ann Ward Mortimer, Morgan Hill, CA (US);
Amirali Talasaz, Atherton, CA (US);
Darya Chudova, San Jose, CA (US);
Helmy Eltoukhy, Atherton, CA (US);
Assignee:
Guardant Health, Inc., Palo Alto, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); C12M 1/00 (2006.01); C12M 1/34 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6855 (2018.01); C12Q 1/6869 (2018.01); G01N 33/574 (2006.01); G16B 20/20 (2019.01); G16B 30/10 (2019.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12M 1/00 (2013.01); C12M 1/34 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6855 (2013.01); C12Q 1/6869 (2013.01); G01N 33/57407 (2013.01); G16B 20/20 (2019.02); G16B 30/10 (2019.02); G16H 50/20 (2018.01); G16H 50/30 (2018.01); C12Q 2600/118 (2013.01); C12Q 2600/154 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/166 (2013.01);
Abstract
Disclosed herein are methods, compositions, and devices for use in the early detection of cancer. The methods include preparing cell-free nucleic acid molecules from a subject for sequencing, sequencing a panel of regions in the cell-free nucleic acid molecules, and detecting one or more markers that are indicative of a cancer.